(Total Views: 82)
Posted On: 12/09/2019 11:10:42 AM
Post# of 27136
$APRE News Article - Aprea Therapeutics Presents Results From French Phase Ib/II Clinical Trial of APR-246 and Azacitidine (AZA) in Patients with TP53 Mutant Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML) at the 2019 American Society of Hematology (ASH) Annu https://marketwirenews.com/news-releases/apre...15996.html
(0)
(0)
My Twitter: WhyteStocks
